Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Status: Recruiting
Location: See all (6) locations...
Study Type: Observational
SUMMARY

Background: People with neurofibromatosis 1 (NF1) who have plexiform neurofibromas (pNFs) can have pain that affects their daily lives. This study aims to improve questionnaires that measure their pain, daily living, and physical functioning.

Objectives: To examine and improve questionnaires about daily living for people with NF1 and pNFs.

Eligibility: People ages 5 and older with NF1 and a pNF

Design: Participants will be screened with medical history. This study will have 2 phases. Phase 1 participants will talk about existing pain assessment questionnaires and how pNFs affect their life. They will have group discussions of up to 8 people of a similar age with NF1 and pNFs, or the parents of children with it. These will last about 90 minutes. Children ages 5 to 7 and their parents will have one-on-one meetings instead. These will last about 45 minutes. Discussions will be audiotaped. After the questionnaires have been changed, individual interviews will discuss the new wording, instructions, questions, and electronic format of the new forms. Phase 2 is now complete. Phase 1 participants may be invited to Phase 2. Phase 2 participants will complete the new questionnaires. These may be pen-and-paper or electronic. The questionnaires will take about 30 minutes for adults and teens. Children will work one-on-one with a staff member and may need up to 45 minutes. A small group of participants will be complete the forms twice-in clinic and 1 month later at home. Also, a small group who start a new pain treatment or have a dose increase in their treatment will complete the forms twice-before the treatment change and 1 month later.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Healthy Volunteers: t
View:

• Primary caregiver (i.e. parent,guardian, grandparent) who is \>= 18 years old of participating subject \<= 17 years old

• Participants must be able to understand, read, and speak the English language

Locations
United States
Washington, D.c.
Children's National Medical Center
COMPLETED
Washington D.c.
Illinois
University of Chicago
ACTIVE_NOT_RECRUITING
Chicago
Maryland
Johns Hopkins University
ACTIVE_NOT_RECRUITING
Baltimore
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Ohio
Cincinnati Children's Hospital and Medical Center Institution
COMPLETED
Cincinnati
Pennsylvania
Children's Hospital of Philadelphia
RECRUITING
Philadelphia
Contact Information
Primary
Pamela L Wolters, Ph.D.
woltersp@mail.nih.gov
(240) 760-6035
Time Frame
Start Date: 2015-11-13
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 486
Treatments
1/Phase 1 Focus Group
Patients with NF1 who have PNs and report experiencing pNF related pain and parents of these patients. (completed)
2/Phase 1 Patients
Patients with NF1 who have pNFs(completed)
3/Phase 1 Parent
Parents of patients in cohort 2 (completed)
4/Phase 2 Patients
Patients with NF1 who have pNFs and recent pNF-related pain
5/Phase 2 Parents
Parents of patients (ages 8-17 years) enrolled in cohort 4
Sponsors
Leads: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov